Environmental impacts of mass drug administration programs: exposures, risks, and mitigation of antimicrobial resistance
Open Access
- 30 June 2022
- journal article
- review article
- Published by Springer Science and Business Media LLC in Infectious Diseases of Poverty
- Vol. 11 (1), 1-14
- https://doi.org/10.1186/s40249-022-01000-z
Abstract
Mass drug administration (MDA) of antimicrobials has shown promise in the reduction and potential elimination of a variety of neglected tropical diseases (NTDs). However, with antimicrobial resistance (AMR) becoming a global crisis, the risks posed by widespread antimicrobial use need to be evaluated. As the role of the environment in AMR emergence and dissemination has become increasingly recognized, it is likewise crucial to establish the role of MDA in environmental AMR pollution, along with the potential impacts of such pollution. This review presents the current state of knowledge on the antimicrobial compounds, resistant organisms, and antimicrobial resistance genes in MDA trials, routes of these determinants into the environment, and their persistence and ecological impacts, particularly in low and middle-income countries where these trials are most common. From the few studies directly evaluating AMR outcomes in azithromycin MDA trials, it is becoming apparent that MDA efforts can increase carriage and excretion of resistant pathogens in a lasting way. However, research on these outcomes for other antimicrobials used in MDA trials is sorely needed. Furthermore, while paths of AMR determinants from human waste to the environment and their persistence thereafter are supported by the literature, quantitative information on the scope and likelihood of this is largely absent. We recommend some mitigative approaches that would be valuable to consider in future MDA efforts. This review stands to be a valuable resource for researchers and policymakers seeking to evaluate the impacts of MDA.Keywords
Funding Information
- Greenwall Foundation
- National Institute of Environmental Health Sciences (T32ES007018)
This publication has 124 references indexed in Scilit:
- Genomic Diversity of Escherichia Isolates from Diverse HabitatsPLOS ONE, 2012
- The effectiveness of sewage treatment processes to remove faecal pathogens and antibiotic residuesJournal of Environmental Science and Health, Part A, 2012
- Selection of Resistant Bacteria at Very Low Antibiotic ConcentrationsPLoS Pathogens, 2011
- Antibiotics for trachomaEmergencias, 2011
- Antibiotic Selection Pressure and Macrolide Resistance in Nasopharyngeal Streptococcus pneumoniae: A Cluster-Randomized Clinical TrialPLoS Medicine, 2010
- Rescuing the bottom billion through control of neglected tropical diseasesThe Lancet, 2009
- The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-reviewThe AAPS Journal, 2008
- Ecotoxicology of human pharmaceuticalsAquatic Toxicology, 2006
- Antimicrobial Use and Antimicrobial Resistance: A Population PerspectiveEmerging Infectious Diseases, 2002
- Pharmacokinetics of Artemisinin-Type CompoundsClinical Pharmacokinetics, 2000